Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV

被引:1
|
作者
Kennedy, Amy J. [1 ,14 ]
McGinnis, Kathleen A. [2 ]
Merlin, Jessica S. [1 ]
Edelman, E. Jennifer [3 ,4 ]
Gordon, Adam J. [5 ,6 ]
Korthuis, P. Todd [7 ]
Skanderson, Melissa [2 ]
Williams, Emily C. [8 ,9 ]
Wyse, Jessica [10 ,11 ]
Oldfield, Benjamin [3 ]
Bryant, Kendall [12 ]
Justice, Amy [2 ,3 ]
Fiellin, David A. [3 ,4 ]
Kraemer, Kevin L. [1 ,13 ]
机构
[1] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA USA
[2] VA Connecticut Healthcare Syst, West Haven, CT USA
[3] Yale Sch Med, Dept Internal Med, New Haven, CT USA
[4] Yale Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT USA
[5] Univ Utah, Program Addict Res Clin Care Knowledge & Advocacy, Dept Internal Med, Div Epidemiol, Salt Lake City, UT USA
[6] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, Salt Lake City, UT USA
[7] Oregon Hlth & Sci Univ, Div Gen Internal Med, Sect Addict Med, Portland, OR 97201 USA
[8] Univ Washington, VA Puget Sound Healthcare Syst, Dept Hlth Serv, Seattle, WA 98195 USA
[9] Seattle Denver Ctr Innovat Vet Centered & Value D, Hlth Serv Res & Dev, VA Puget Sound Healthcare Syst, Seattle, WA USA
[10] VA Portland Healthcare Syst, Portland, OR USA
[11] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA
[12] NIAAA, Bethesda, MD USA
[13] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA
[14] Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA
基金
美国国家卫生研究院;
关键词
HIV; Opioid use disorder; Veterans; Medication treatment; Behavioral treatment; SUBSTANCE-ABUSE TREATMENT; CARE; BUPRENORPHINE/NALOXONE; PHARMACOTHERAPY; THERAPY;
D O I
10.1016/j.jsat.2021.108509
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Persons with HIV (PWH) and opioid use disorder (OUD) can have poor health outcomes. We assessed whether intensity of behavioral treatment for OUD (BOUD) with and without medication for OUD (MOUD) is associated with improved HIV clinical outcomes. Methods: We used Veterans Aging Cohort Study (VACS) data from 2008 to 2017 to identify PWH and OUD with 0.01). VL, CD4 count and VACS Index 2.0 did not differ by BOUD or 6 months of MOUD treatment. Conclusion: Among PWH and OUD who initiated BOUD, higher intensity BOUD was associated with improved ART initiation and adherence, but neither BOUD alone nor BOUD plus >6 months MOUD was associated with improvements in VL, CD4 count or VACS Index 2.0.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] IMPACT OF COMORBID PAIN, PSYCHIATRIC DIAGNOSES, AND SUBSTANCE USE DISORDERS ON OPIOID USE DISORDER TREATMENT IN PERSONS WITH AND WITHOUT HIV
    Miller, E.
    McGinnis, K.
    Kerns, R.
    Gordon, K.
    Edelman, J.
    Justice, A.
    Feinberg, T.
    McRae, M.
    Patterson, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S5 - S6
  • [2] IMPACT OF COMORBID PAIN, PSYCHIATRIC DIAGNOSES, AND SUBSTANCE USE DISORDERS ON OPIOID USE DISORDER TREATMENT IN PERSONS WITH AND WITHOUT HIV
    Miller, E.
    McGinnis, K.
    Kerns, R.
    Gordon, K.
    Edelman, J.
    Justice, A.
    Feinberg, T.
    Mcrae, M.
    Patterson, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S55 - S55
  • [3] Medications for Treatment of Opioid Use Disorder among Persons Living with HIV
    Fanucchi, Laura
    Springer, Sandra A.
    Korthuis, P. Todd
    [J]. CURRENT HIV/AIDS REPORTS, 2019, 16 (01) : 1 - 6
  • [4] Impact of behavioral and medication treatment for alcohol use disorder on changes in HIV-related outcomes among patients with HIV: A longitudinal analysis
    McGinnis, Kathleen A.
    Skanderson, Melissa
    Edelman, E. Jennifer
    Gordon, Adam J.
    Korthuis, P. Todd
    Oldfield, Benjamin
    Williams, Emily C.
    Wyse, Jessica
    Bryant, Kendall
    Fiellin, David A.
    Justice, Amy C.
    Kraemer, Kevin L.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2020, 217
  • [5] Medications for Treatment of Opioid Use Disorder among Persons Living with HIV
    Laura Fanucchi
    Sandra A. Springer
    P. Todd Korthuis
    [J]. Current HIV/AIDS Reports, 2019, 16 : 1 - 6
  • [6] Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder
    Biondi, Breanne E.
    Mohanty, Subhasis
    Vander Wyk, Brent
    Montgomery, Ruth R.
    Shaw, Albert C.
    Springer, Sandra A.
    [J]. CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2021, 21
  • [7] Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use Disorder
    Cook, Ryan R.
    Jaworski, Erin N.
    Hoffman, Kim A.
    Waddell, Elizabeth N.
    Myers, Renae
    Korthuis, P. Todd
    Vergara-Rodriguez, Pamela
    [J]. SUBSTANCE ABUSE, 2023, 44 (04) : 301 - 312
  • [8] TREATMENT FOR ALCOHOL USE DISORDER AMONG PERSONS WITH AND WITHOUT HIV IN A CLINICAL SETTING
    Davy-Mendez, T.
    Sarovar, V.
    Levine-Hall, T.
    Lea, A. N.
    Palzes, V. A.
    Chi, F. W.
    Sterling, S. A.
    Weisner, C. M.
    Silverberg, M. J.
    Satre, D. D.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 : 133A - 133A
  • [9] Evaluation of the Impact of HIV Serostatus on the Hepatitis C Virus Care Cascade and Injection Drug Use Among Persons Initiating Medication Treatment for Opioid Use Disorder
    Lier, Audun J.
    Wyk, Brent Vander
    Di Paola, Angela
    Springer, Sandra A.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (11):
  • [10] Outcomes of adding cognitive behavioral therapy to medication-assisted treatment for opioid use disorder
    LeBlanc, Taylor
    Cromer, Pamela
    Gilliam, Stephen
    Johnson, Aaron
    Garvin, Jane
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2024, 36 (01) : 57 - 64